Implications of human induced pluripotent stem cells in metabolic disorders: from drug discovery toward precision medicine

被引：13
|
作者：
Cota-Coronado, Agustin [1 ]
Berenice Ramirez-Rodriguez, P. [2 ]
Padilla-Camberosl, Eduardo [1 ]
Diaz, eNstor F. [2 ]
Flores-Fernandez, Jose M. [3 ,4 ]
Avila-Gonzalez, Daniela [1 ,2 ]
Emmanuel Diaz-Martinez, N. [1 ]
机构：
[1] Ctr Invest & Asistencia Tecnol & Diseno Estado Ja, Biotecnol Med & Farmaceut, Guadalajara, Mexico
[2] Inst Nacl Perinatol, Dept Fisiol & Desarrollo Celular, Ciudad De Mexico, Mexico
[3] Univ Alberta, Dept Biochem, 474 Med Sci Bldg, Edmonton, AB T6G 2R3, Canada
[4] Tecnol Estudios Super Villa Guerrero, Div Ingn Ind Alimentarias & Innovac Agr Sustentab, Carretera Toluca Ixtapan Sal,Km 64-5, Villa Guerrero 61763, Estado De Mexic, Mexico
来源：
DRUG DISCOVERY TODAY | 2019年 / 24卷 / 01期
关键词：
INSULIN-PRODUCING CELLS; ENDOTHELIAL-CELLS; GENE CORRECTION; BETA-CELLS; GENERATION; LIVER; ADULT; DIFFERENTIATION; INDUCTION; THERAPY;
D O I：
10.1016/j.drudis.2018.10.001
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Human induced pluripotent stem cells (hiPSCs) enable in vitro high-throughput pharmacological screening assays of diseased tissue. Together with recent genome-wide association studies (GWAS), hiPSCs enable the identification of key mutations for the development of effective treatments based on precise drugs. In concert with CRISPR/Cas9 systems, hiPSC technology can reveal therapeutic targets in metabolic disorders. The ex vivo CRISPR correction of autologous patient-derived hiPSCs has led to the development of replacement cell therapies, providing better patient prognoses.
引用
收藏
页码：334 / 341
页数：8
相关论文
共 50 条
  • [31] Human-induced pluripotent stem cells as models for rare cardiovascular diseases: from evidence-based medicine to precision medicine
    Pan, Ziwei
    Ebert, Antje
    Liang, Ping
    PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 2021, 473 (07): : 1151 - 1165
  • [32] Using Human-Induced Pluripotent Stem Cells to Model Monogenic Metabolic Disorders of the Liver
    Ordonez, Maria Paulina
    Goldstein, Lawrence S. B.
    SEMINARS IN LIVER DISEASE, 2012, 32 (04) : 298 - 306
  • [33] Precision Medicine in Parkinson's Disease Using Induced Pluripotent Stem Cells
    Kim, Min Seong
    Kim, Hyesoo
    Lee, Gabsang
    ADVANCED HEALTHCARE MATERIALS, 2024, 13 (21)
  • [34] Modeling human neurological disorders with induced pluripotent stem cells
    Imaizumi, Yoichi
    Okano, Hideyuki
    JOURNAL OF NEUROCHEMISTRY, 2014, 129 (03) : 388 - 399
  • [35] Modeling Neurological Disorders by Human Induced Pluripotent Stem Cells
    Kunkanjanawan, Tanut
    Noisa, Parinya
    Parnpai, Rangsun
    JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY, 2011,
  • [36] Human induced pluripotent stem cells for modelling neurodevelopmental disorders
    Karthikeyan Ardhanareeswaran
    Jessica Mariani
    Gianfilippo Coppola
    Alexej Abyzov
    Flora M. Vaccarino
    Nature Reviews Neurology, 2017, 13 : 265 - 278
  • [37] Human induced pluripotent stem cells for modelling neurodevelopmental disorders
    Ardhanareeswaran, Karthikeyan
    Mariani, Jessica
    Coppola, Gianfilippo
    Abyzov, Alexej
    Vaccarino, Flora M.
    NATURE REVIEWS NEUROLOGY, 2017, 13 (05) : 265 - 278
  • [38] Rapid and efficient generation of human oligodendrocytes from induced pluripotent stem cells for in vitro disease modelling and drug discovery
    Ehrlich, M.
    Starost, L.
    Mozafari, S.
    Glatza, M.
    Velychko, S.
    Cui, Q. -L.
    Antel, J.
    Schoeler, H. R.
    Baron-van Evercooren, A.
    Kuhlmann, T.
    GLIA, 2017, 65 : E384 - E385
  • [39] Induced pluripotent stem cells for disease modeling, cell therapy and drug discovery in genetic autonomic disorders: a review
    Kenyi Saito-Diaz
    Nadja Zeltner
    Clinical Autonomic Research, 2019, 29 : 367 - 384
  • [40] Induced pluripotent stem cells for disease modeling, cell therapy and drug discovery in genetic autonomic disorders: a review
    Saito-Diaz, Kenyi
    Zeltner, Nadja
    CLINICAL AUTONOMIC RESEARCH, 2019, 29 (04) : 367 - 384
12345